Best in 7 days
Pay in installments of $5.69 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 4 - Jul 9
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
.. , She was in the Retatrutide clinical trial for 20 months. Lost 37% of her body weight. Then stopped cold turkey., Mimi in Aus joins Paddy and Belinda on The Dose to talk Semaglutide Cyanocobalamin Dynamic3 Health where to get semaglutide How To Get Semaglutide Forbes Health Unlock Your Longevity Potential: Center for Aesthetic Medicine's Revolutionary GLP 1 Wellness Program Center for Aesthetic Medicine Reexamining Fat: Exploring Diversity, Plasticity, Development, Functional Implication, and Therapeutic Options starting retatrutide dose Retatrutide Starting Dose
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
Discover Niche Categories That Outsell travelling with semaglutide
Top-Converting Item to Boost Your Average Order
Best in 7 days
Best in 7 days
Best in 7 days
Best in 7 days
4.4 ★★★★★
Based on 274 reviews
Sort
Product Reviews
★★★★★ 5
A MUST read for any patient with cancer or for a physician
Format: Kindle
I would give this book 6 stars if I could.
The book talks about medical care and cancer care in the United States. The care that many receive is very limited for the poor and poorly managed for the rich or well insured. We need treatments that have a scientific basis and a proven track record.
Often Patients get pushed into testing that has not been shown to prolong life or decrease morbidity. A good example is PSA testing. The potential therapies can kill you or drastically take away quality of life. Would you take a test that might lead to wearing diapers for the rest of you life and not prolong your life ? If Your PSA is elevated does your doctor offer you 3 or 4 possible treatments and compare possible and likely outcomes?
Is there any financial incentives for the proposed therapy? Is there an expensive piece of equipment that needs to be paid for? Have you been given a list of alternatives and expected outcomes?
Unfortunately the current medical health care system is flooded with ignorance, apathy and often greed.
Consumers (patient) need to know something about their disease. They must become active players. They should ask for proof that this therapy is better than another therapy. They also need to be able to ask their doctors "how many of these have you done and what outcomes have you had?"
They need real expectations. If you have localized prostate disease that has a low risk of metastasis then why get the prostate ripped out ? Maybe it can be watched for 4 - 5 years before surgery and diapers and impotence.
Greed? Yes boys and girls somebody has to pay for that 3 million dollar particle accelerator at your local hospital. Why should it be your life and body for some unproven therapy?
Unfortunately education is a very difficult thing to do.
You can tell I loved this book.
Why is it the USA has such poor health outcomes?
Over treatment can cause harm. Bone Marrow transplants for breast cancer is proof of the harm.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on July 7, 2014
★★★★★ 5
This book will educate and inform! A+
Format: Paperback
Now in my 7th decade, I spent my entire career in the pharmaceutical manufacturing industry. I can attest to the veracity of Dr. Brawley's dissertation. The maxim that all physicians and surgeons promise is the essential promise to "First, do no harm." Dr. Brawley teaches that not all who purport to care for us and our loved ones adhere to this promise.
Just ask a vet. On the battlefield virtually all medical care is superb. Here at home, alas, it is not so.
Too often, not always, but way too often he is right. Here's the bottom line. If you're not comfortable with what your being told about your health, or that of a loved one, don't hesitate, find another MD who though you may not like what they may say to you, you trust them with your life. That is exactly what you're doing. Much of the seeming heroics in medicine/surgery are really about making or saving money for the drug industry, or hospital, or doctor, or insurance carrier, and not about saving your backside. Certainly not always, perhaps not even most of the time, but way too often.
Read this book and you'll be radically better equipped to understand just what may be driving the responses of the health care systems to your malady, and how you can assure the appropriate care for yourself or a loved one. Are there great doctors and hospitals out there? You bet there are. There are also those who couldn't care less about quality health care for you and are only focused on their own backside. This book will educate and inform you.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on August 20, 2016
★★★★★ 5
"More" is not "better"
Format: Kindle
I had the privilege of working with Otis during part of his training at the National Cancer Institute at a time that policies on PSA and mammography screening were being newly scrutinized with respect to risk/benefit. The notion that screening might actually do more harm than good was seen as absolute heresy and I fondly remember the wonder and amazement in Otis' eyes as he unraveled to me just how this counter-intuitive idea could be so. Twenty years later, the truths I learned from Otis back then are still not widely appreciated among patients, indeed even doctors more sadly. I eagerly snatched this book up not only because I knew Otis and expected a riveting review of healthcare but because my experience in pharmaceutical development has led me to participate unintentionally in some of the perverse systems of conflicts of interest that characterize our healthcare system. I am at a personal watershed and this book is a strong antidote for what ails me, i.e. I feel emboldened to take my career in the direction of a solution rather than continue to contribute to the problem. Written for the general audience, We Do Harm breaks the ranks of legions of doctors who are invested in perpetuating a broken but remunerative healthcare system by introducing specific and by no means isolated instances where patients have been harmed. This book is at once disparaging of blind trust of one's physician and optimistic in that some stars like Otis and microcosms like Grady Memorial can and do avoid patient-disadvantaged conflicts of interest. This book provides evidence and motivation for every person in every role they engage in in the healthcare system: patient, consumer, provider, insurer, politician. No one can escape the relevance and import of the key message of this book that "more" is not always "better." Until such time, if ever, that our healthcare system operates under transparency, this is a must read for all. That means you! Now! It can't wait! I am a believer that healthcare quality will come from the bottom up and not the top down and this book exemplifies this spirit; read it and be empowered to ask the hard questions as to who is motivated to provide what care and at what personal gain.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 14, 2013
★★★★★ 5
I got what I needed.
Format: Paperback
I got the book I needed for school in a timely manner.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 9, 2021
★★★★★ 5
Amazing recourse, even while in nursing school
Format: Paperback
I buy this for everyone I know how gets into nursing school. It helped me as a resource while in school. Topics are a few pages, unlike your textbook where they are 30-60 pages
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on March 26, 2026
